| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | President, Director | Common Stock | 719,005 | $1,445,200 | $2.01 | 22 Jan 2026 | Direct |
| Clearside Biomedical, Inc. | Director | Common Stock | 17,957 | $23,524 | $1.31 | 15 May 2024 | Direct |
| Clearside Biomedical, Inc. | Director | Stock Option (right to buy) | 45,000 | 20 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | 22 Jan 2026 | 1 | $0 | 4 | President, Director | 26 Jan 2026, 19:51 |
| IRD | Opus Genetics, Inc. | 22 Oct 2025 | 1 | -$46,400 | 4 | President, Director | 24 Oct 2025, 16:16 |
| IRD | Opus Genetics, Inc. | 21 Nov 2024 | 1 | +$9,834 | 4 | President, Director | 25 Nov 2024, 16:18 |
| IRD | Opus Genetics, Inc. | 07 Nov 2024 | 1 | $0 | 4 | President, Director | 12 Nov 2024, 16:35 |
| IRD | Opus Genetics, Inc. | 22 Oct 2024 | 0 | $0 | 3 | President, Director | 24 Oct 2024, 17:54 |
| CLSD | Clearside Biomedical, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:15 |
| CLSD | Clearside Biomedical, Inc. | 15 May 2024 | 1 | +$10,235 | 4 | Director | 15 May 2024, 17:28 |
| CLSD | Clearside Biomedical, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:36 |
| CLSD | Clearside Biomedical, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:27 |
| CLSD | Clearside Biomedical, Inc. | 02 Mar 2022 | 1 | $0 | 4 | Director | 04 Mar 2022, 16:09 |
| CLSD | Clearside Biomedical, Inc. | 02 Mar 2022 | 0 | $0 | 3 | Director | 04 Mar 2022, 15:56 |